JanOne Inc. (NASDAQ:JAN – Get Rating) was the target of a large drop in short interest during the month of April. As of April 15th, there was short interest totalling 58,300 shares, a drop of 52.2% from the March 31st total of 122,000 shares. Approximately 3.0% of the company’s shares are short sold. Based on […]
/PRNewswire/ JanOne (Nasdaq: JAN), the biopharmaceutical innovator specializing in non-addicting painkillers and new treatments for the causes of pain, has.
JanOne (JAN) Completes Pre-IND Meeting with FDA on Jan123 streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
JanOne Inc. (NASDAQ:JAN – Get Rating) was the recipient of a significant increase in short interest during the month of March. As of March 31st, there was short interest totalling 122,000 shares, an increase of 672.2% from the March 15th total of 15,800 shares. Based on an average daily volume of 391,700 shares, the short-interest […]